Nanovibronix Inc (NQ: NAOV )
0.7508
+0.0208
(+2.85%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jul 26, 2024
Add to My Watchlist
All News about Nanovibronix Inc
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Provides Business Update in Letter to Shareholders
November 15, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20091.jpeg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement
October 19, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18151.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's After-Market Session
September 29, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17803.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17754.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/27/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/26/image_3.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/26/image_1.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract
September 23, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Sets Date for Annual Shareholder Meeting
September 14, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Provides Business Update in Letter to Shareholders
August 18, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14898.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14879.jpeg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_11029.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/06/23/yesterdays_movers.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_10857.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/15/image_6.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Advances Efforts to Achieve NHS Approval
April 05, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_5496.jpeg)
![](https://investorplace.com/wp-content/uploads/2022/03/penny-stocks-1024x576.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.